• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Advertisement
    Home › Authors › Posts by Tom Murphy

    Tom Murphy

    Tom Murphy

    Read the latest stories and analysis from Tom Murphy.

    Royalty Pharma lets Elan takeover bid expire Business

    Royalty Pharma lets Elan takeover bid expire

    Tom Murphy · June 18, 2013 1:06 pm
    Drugmaker Elan plans to explore sale of company Business

    Drugmaker Elan plans to explore sale of company

    Tom Murphy · June 14, 2013 4:49 pm
    Accenture forecasts fast retail clinic growth Business

    Accenture forecasts fast retail clinic growth

    Tom Murphy · June 12, 2013 7:15 pm
    Exide files for Chapter 11 bankruptcy protection Business

    Exide files for Chapter 11 bankruptcy protection

    Tom Murphy · June 10, 2013 1:16 pm
    Advertisement
    Royalty Pharma raises offer to buy drugmaker Elan Business

    Royalty Pharma raises offer to buy drugmaker Elan

    Tom Murphy · June 7, 2013 5:52 pm
    UnitedHealth board OKs quarterly dividend raise Business

    UnitedHealth board OKs quarterly dividend raise

    Tom Murphy · June 5, 2013 3:05 pm
    Dell board recommends Michael Dell buyout offer Business

    Dell board recommends Michael Dell buyout offer

    Tom Murphy · May 31, 2013 6:18 pm
    Cigna 1Q profit plunges on Berkshire deal charge Business

    Cigna 1Q profit plunges on Berkshire deal charge

    Tom Murphy · May 2, 2013 12:06 pm
    Advertisement
    Humana 1Q profit soars, insurer’s forecast rises Business

    Humana 1Q profit soars, insurer’s forecast rises

    Tom Murphy · May 1, 2013 2:21 pm
    Aetna 1Q profit slips 4 pct, boosts 2013 forecast Business

    Aetna 1Q profit slips 4 pct, boosts 2013 forecast

    Tom Murphy · April 30, 2013 4:01 pm
    Health insurer WellPoint’s 1Q profit rises 3 pct Business

    Health insurer WellPoint’s 1Q profit rises 3 pct

    Tom Murphy · April 24, 2013 11:21 pm
    Drugmaker Lilly’s 1Q profit up, tops expectations Business

    Drugmaker Lilly’s 1Q profit up, tops expectations

    Tom Murphy · April 24, 2013 5:17 pm
    Advertisement
    • ‹Previous page
    • 1
    • …
    • 4
    • 5
    • 6
    • 7
    • 8
    • …
    • 11
    • ›Next page
    Page 6 of 11
    Advertisement
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.